Anzer Khan
Impact in
-
- Ovarian cancer diagnosis and treatment
-
- RNA regulation and disease
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- CRISPR and Genetic Engineering
Papers in
-
- RNA regulation and disease 6
- RNA Research and Splicing 5
- CRISPR and Genetic Engineering 2
- Ubiquitin and proteasome pathways 1
- Oncology 3
- Inflammatory Biomarkers in Disease Prognosis 1
- Co-authors
- Mary A. O’Connell (5 shared papers)Liam P. Keegan (5 shared papers)Dragana Vukić (3 shared papers)Jiří Sedmík (2 shared papers)Jaclyn Quin (1 shared paper)Nagraj Sambrani (3 shared papers)Leeanne McGurk (2 shared papers)Kunle Odunsi (3 shared papers)
- Journals
- Immunobiology (3 papers)Gynecologic Oncology (2 papers)Nature Communications (1 paper)RNA (1 paper)Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (1 paper)
- Partner nations
- United StatesCzechiaUnited Kingdom
In The Last Decade
Anzer Khan
10 papers receiving 294 citations
Peers
Comparison fields: 5 of 47
- Reproductive Medicine 31
- Molecular Biology 212
- Cancer Research 38
- Immunology 54
- Virology 5
Countries citing papers authored by Anzer Khan
This map shows the geographic impact of Anzer Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anzer Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anzer Khan more than expected).
Fields of papers citing papers by Anzer Khan
This network shows the impact of papers produced by Anzer Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anzer Khan. The network helps show where Anzer Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Anzer Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 83 | |
| 2 | 2020 | 56 | |
| 3 | 2017 | 54 | |
| 4 | 2021 | 33 | |
| 5 | 2018 | 23 | |
| 6 | 2017 | 19 | |
| 7 | 2020 | 18 | |
| 8 | 2014 | 6 | |
| 9 | 2022 | 3 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 0 | |
| 12 | 2025 | 0 |
About Anzer Khan
Anzer Khan is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Reproductive Medicine, having authored 12 papers that have together received 296 indexed citations. Recurring topics across this work include RNA regulation and disease (6 papers), RNA Research and Splicing (5 papers), Ovarian cancer diagnosis and treatment (2 papers), interferon and immune responses (2 papers), CRISPR and Genetic Engineering (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Ubiquitin and proteasome pathways (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Reproductive Medicine (31 citations), Molecular Biology (212 citations), Cancer Research (38 citations), Immunology (54 citations) and Virology (5 citations). Anzer Khan has collaborated with scholars based in United States, Czechia and United Kingdom. Frequent co-authors include Mary A. O’Connell, Liam P. Keegan, Dragana Vukić, Jiří Sedmík, Jaclyn Quin, Nagraj Sambrani, Leeanne McGurk, Kunle Odunsi, Tiffany R. Emmons and Kelly L. Singel. Their work appears in journals such as Immunobiology, Gynecologic Oncology, Nature Communications, RNA and Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.